CooperSurgical buys infertility company Ackrad
This article was originally published in Clinica
The Cooper Companies' gynaecological unit, CooperSurgical, has bought private company Ackrad Laboratories for $12 million. Ackrad, which had turnover of $5 million in 2001, develops disposable devices for the assessment of infertility and other gynaecological disorders. Lake Forest, California-based Cooper Companies expects the acquisition will add to earnings per share after one year.